Latest news & insights
Boyds adds medical writer, Vicky Wheeldon, to growing Regulatory Affairs team
We are delighted to announce the appointment of experienced clinical researcher Vicky Wheeldon as Associate Medical Writer in response to sustained demand for our dedicated
Julie Warner: A regulatory roadmap to translation of ATMPs
Dr Julie Warner, Vice President of Regulatory Affairs, will be taking part in the ‘From Concept to Clinic’ event hosted by Medcity and the South
Boyds bolsters clinical operations team as demand for clinical trial expertise and support surges
We are delighted to announce the appointment of experienced clinical researcher Caroline Corbett as Director of Clinical Operations to support the team’s continued growth and
Dr Karen Mullen appointed as Chief Medical Officer
Boyds is delighted to announce the appointment of experienced pharmaceutical physician Dr Karen Mullen FFPM as Chief Medical Offer (CMO) and Vice President of Clinical
Strong growth in the US boosts revenue for Boyds
Boyds is delighted to report another strong year of growth, with an increase in excess of 20 percent year-on-year in annual revenue in the wake
Boyds boosts specialist clinical expertise with appointment of Dr Harriet Gray Stephens
Boyds is delighted to announce the appointment of Pharmaceutical Physician, Dr Harriet Gray Stephens, to the Clinical and Medical Affairs group to further strengthen the
Katy Rudnick awarded Aiko Maruya award for Excellence in Regulatory Science
Boyds congratulates Katy Rudnick, Vice President and Head of US Regulatory Affairs, on being awarded the Aiko Maruya Award from the USC School of Pharmacy.
Pippa Bjaaland graduates with MSc in Cancer and Clinical Oncology with distinction.
Boyds is delighted to congratulate Pippa Bjaaland, Senior CRA at Boyds, on graduating with an MSc in Cancer and Clinical Oncology from Queen Mary University
